193 related articles for article (PubMed ID: 28781283)
21. Sequential eradication of Helicobacter pylori as a treatment for immune thrombocytopenia in patients with moderate thrombocytopenia: a multicenter prospective randomized phase 3 study.
Han B; Kim HJ; Yhim HY; Oh D; Bae SH; Shin HJ; Lee WS; Kwon J; Lee JO; Kim HJ; Bang SM
Ann Hematol; 2022 Jul; 101(7):1435-1445. PubMed ID: 35643952
[TBL] [Abstract][Full Text] [Related]
22. Platelet count response to H. pylori treatment in patients with immune thrombocytopenic purpura with and without H. pylori infection: a systematic review.
Arnold DM; Bernotas A; Nazi I; Stasi R; Kuwana M; Liu Y; Kelton JG; Crowther MA
Haematologica; 2009 Jun; 94(6):850-6. PubMed ID: 19483158
[TBL] [Abstract][Full Text] [Related]
23. Iron deficiency anemia successfully treated by Helicobacter pylori eradication in a patient with idiopathic thrombocytopenic purpura.
MORITA R; HASHINO S; OKADA K; TAKAHATA M; ONOZAWA M; KAHATA K; KONDO T; IMAMURA M; ASAKA M
Rinsho Ketsueki; 2009 Nov; 50(11):1655-7. PubMed ID: 20009444
[TBL] [Abstract][Full Text] [Related]
24. Congenital and acquired thrombocytopenia.
Cines DB; Bussel JB; McMillan RB; Zehnder JL
Hematology Am Soc Hematol Educ Program; 2004; ():390-406. PubMed ID: 15561694
[TBL] [Abstract][Full Text] [Related]
25. Effects of a Helicobacter pylori eradication regimen on anti-platelet autoantibody response in infected and uninfected patients with idiopathic thrombocytopenic purpura.
Asahi A; Kuwana M; Suzuki H; Hibi T; Kawakami Y; Ikeda Y
Haematologica; 2006 Oct; 91(10):1436-7. PubMed ID: 16963398
[TBL] [Abstract][Full Text] [Related]
26. [Idiopathic thrombocytopenic purpura (ITP) and H. pylori eradication].
Hashino S
Nihon Rinsho; 2005 Nov; 63 Suppl 11():303-7. PubMed ID: 16363549
[No Abstract] [Full Text] [Related]
27. Effect of Helicobacter pylori eradication in patients with chronic idiopathic thrombocytopenic purpura-a randomized controlled trial.
Suzuki T; Matsushima M; Masui A; Watanabe K; Takagi A; Ogawa Y; Shirai T; Mine T
Am J Gastroenterol; 2005 Jun; 100(6):1265-70. PubMed ID: 15929755
[TBL] [Abstract][Full Text] [Related]
28. [Clinical significance of Helicobacter pylori in pathogenesis of idiopathic thrombocytopenic purpura].
Kong R; Qiu HC; Wu PF; Niu XH; Shen WX; Wang Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1222-6. PubMed ID: 18928633
[TBL] [Abstract][Full Text] [Related]
29. Analysis of B- and T-cell clonality and HLA class II alleles in patients with idiopathic thrombocytopenic purpura: correlation with Helicobacter pylori infection and response to eradication treatment.
Veneri D; De Matteis G; Solero P; Federici F; Zanuso C; Guizzardi E; Arena S; Gaio M; Pontiero P; Ricetti MM; Franchini M
Platelets; 2005 Aug; 16(5):307-11. PubMed ID: 16011982
[TBL] [Abstract][Full Text] [Related]
30. Long term changes in platelet counts after H. pylori eradication in non-ITP patients.
Matsukawa Y; Iwamoto M; Kato K; Mizuno S; Gon Y; Hemmi A; Shirinskaya N; Takeuchi J; Sawada S
Platelets; 2010; 21(8):628-31. PubMed ID: 20849211
[TBL] [Abstract][Full Text] [Related]
31. Helicobacter pylori infection and immune thrombocytopenic purpura: an update.
Franchini M; Veneri D
Helicobacter; 2004 Aug; 9(4):342-6. PubMed ID: 15270749
[TBL] [Abstract][Full Text] [Related]
32. Characteristics of Helicobacter pylori-induced gastritis and the effect of H. pylori eradication in patients with chronic idiopathic thrombocytopenic purpura.
Ando T; Tsuzuki T; Mizuno T; Minami M; Ina K; Kusugami K; Takamatsu J; Adachi K; El-Omar E; Ohta M; Goto H
Helicobacter; 2004 Oct; 9(5):443-52. PubMed ID: 15361084
[TBL] [Abstract][Full Text] [Related]
33. Does Helicobacter pylori eradication play a role in immune thrombocytopenia?
Llovet V; Rada G
Medwave; 2016 Sep; 16 Suppl 3():e6528. PubMed ID: 27603101
[TBL] [Abstract][Full Text] [Related]
34. Does H. Pylori infection play a role in idiopathic thrombocytopenic purpura and in other autoimmune diseases?
Gasbarrini A; Franceschi F
Am J Gastroenterol; 2005 Jun; 100(6):1271-3. PubMed ID: 15929756
[TBL] [Abstract][Full Text] [Related]
35. [Improvement in platelet count after 3rd-line and 4th-line eradication therapy for Helicobacter pylori in patients with immune thrombocytopenia].
Jomen W; Sato T; Maesawa C
Rinsho Ketsueki; 2017; 58(2):126-131. PubMed ID: 28321089
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic approaches to secondary immune thrombocytopenic purpura.
Bussel JB
Semin Hematol; 2009 Jan; 46(1 Suppl 2):S44-58. PubMed ID: 19245934
[TBL] [Abstract][Full Text] [Related]
37. Clinical characteristics and treatment outcomes in patients with Helicobacter pylori-positive chronic immune thrombocytopenic purpura.
Teawtrakul N; Sawadpanich K; Sirijerachai C; Chansung K; Wanitpongpun C
Platelets; 2014; 25(7):548-51. PubMed ID: 24176049
[TBL] [Abstract][Full Text] [Related]
38. Platelet activation in Helicobacter pylori-associated idiopathic thrombocytopenic purpura: eradication reduces platelet activation but seldom improves platelet counts.
Ahn ER; Tiede MP; Jy W; Bidot CJ; Fontana V; Ahn YS
Acta Haematol; 2006; 116(1):19-24. PubMed ID: 16809885
[TBL] [Abstract][Full Text] [Related]
39. Comparison of platelet transfusion effectiveness between Helicobacter pylori-positive and -negative immune thrombocytopenia.
Tabata S; Hosoi H; Wan K; Sakaki A; Mushino T; Murata S; Tomiyama Y; Sonoki T
Br J Haematol; 2024 May; 204(5):1953-1957. PubMed ID: 38522847
[TBL] [Abstract][Full Text] [Related]
40. Platelet recovery after eradication of Helicobacter pylori in patients with idiopathic thrombocytopenic purpura.
Hino M; Yamane T; Park K; Takubo T; Ohta K; Kitagawa S; Higuchi K; Arakawa T
Ann Hematol; 2003 Jan; 82(1):30-2. PubMed ID: 12574961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
